{
  "id": 5609,
  "text": "The Lancet (London, England), 393, 169-182.https://doi.org/10.1016/S0140-6736(18)32470-X [5] Xie, X., Song, K., Cui, B., et al.(2018) A Comparison of the Prognosis between Adenocarcinoma and Squamous Cell Carcinoma in Stage IB-IIA Cervical Cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The Lancet (London, England), 393, 169-182.https://doi.org/10.1016/S0140-6736(18)32470-X [5] Xie, X., Song, K., Cui, B., et al.(2018) A Comparison of the Prognosis between Adenocarcinoma and Squamous Cell Carcinoma in Stage IB-IIA Cervical Cancer.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌的IB-IIA期中，腺癌与鳞状细胞癌的预后有所不同。通常情况下，鳞状细胞癌的治疗效果和预后较为良好，而腺癌由于生物学行为的差异，常常表现出更具侵袭性的特征，因此其预后相对较差。临床数据显示，鳞状细胞癌患者在接受标准治疗后的生存率较高，而腺癌患者则可能面临更高的复发风险和较低的生存率。因此，在治疗策略的选择上可能需要更加深入的考量，包括更加密切的随访和个体化治疗方案的制定，以提高腺癌患者的预后。",
  "query": "宫颈癌中腺癌与鳞状细胞癌在IB-IIA期的预后有什么不同？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌中腺癌与鳞状细胞癌在IB-IIA期的预后有什么不同？\n\n<reference text>: The Lancet (London, England), 393, 169-182.https://doi.org/10.1016/S0140-6736(18)32470-X [5] Xie, X., Song, K., Cui, B., et al.(2018) A Comparison of the Prognosis between Adenocarcinoma and Squamous Cell Carcinoma in Stage IB-IIA Cervical Cancer.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌的IB-IIA期中，腺癌与鳞状细胞癌的预后有所不同。通常情况下，鳞状细胞癌的治疗效果和预后较为良好，而腺癌由于生物学行为的差异，常常表现出更具侵袭性的特征，因此其预后相对较差。临床数据显示，鳞状细胞癌患者在接受标准治疗后的生存率较高，而腺癌患者则可能面临更高的复发风险和较低的生存率。因此，在治疗策略的选择上可能需要更加深入的考量，包括更加密切的随访和个体化治疗方案的制定，以提高腺癌患者的预后。"
}